School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Surgery. 2022 Aug;172(2):602-611. doi: 10.1016/j.surg.2022.02.017. Epub 2022 Apr 3.
Opioid overprescribing after surgery is a significant public health issue in most developed countries, including New Zealand. However, there is a lack of literature on the patterns and risk factors for postoperative opioid use among general surgical patients in New Zealand. This study aimed to examine opioid use in patients undergoing general surgery at Auckland District Health Board between January and December 2019 and to identify factors associated with opioid use after surgery and persistent opioid use (defined as having filled ≥1 opioid prescription in the 91 to 180 days after surgery).
This is a retrospective cohort study. Data from patients' electronic clinical records and community pharmacy dispensing records were extracted to obtain data on sociodemographics, surgical characteristics, comorbidities, co-prescribed medications, and opioid use.
A total of 1,110 patients were included in the study, with 42.4% dispensed an opioid following discharge after surgery. Of opioid-naïve patients who filled opioids after surgery (n = 401), 9.5% became persistent opioid users. Preoperative use of nonopioid analgesics, longer hospital stays, higher operation severity, procedure type, and higher pain scores were positively associated with opioid use, whereas older age was a negative predictor. Longer hospital stays, an initial discharge prescription with high opioid load, and female sex increased the risk of persistent opioid use. Conversely, a higher severity of surgery was associated with lower risk of persistent opioid use.
The findings suggest that a considerable proportion of patients become persistent opioid users after surgery. The risk factors identified can guide clinicians to prescribe in a manner that reduces opioid-related adverse outcomes and help guide future interventions.
在大多数发达国家,包括新西兰,手术后阿片类药物过量处方是一个重大的公共卫生问题。然而,关于新西兰普通外科患者手术后阿片类药物使用的模式和风险因素的文献很少。本研究旨在调查奥克兰地区卫生局 2019 年 1 月至 12 月期间接受普通外科手术的患者的阿片类药物使用情况,并确定与手术后阿片类药物使用和持续阿片类药物使用(定义为在手术后 91 至 180 天内填写≥1 份阿片类药物处方)相关的因素。
这是一项回顾性队列研究。从患者的电子临床记录和社区药房配药记录中提取数据,以获取社会人口统计学、手术特征、合并症、共开药物和阿片类药物使用的数据。
共有 1110 名患者纳入研究,其中 42.4%的患者在手术后出院时开具了阿片类药物。在手术后服用阿片类药物的阿片类药物初治患者(n=401)中,9.5%成为持续阿片类药物使用者。术前使用非阿片类镇痛药、住院时间延长、手术严重程度较高、手术类型和较高的疼痛评分与阿片类药物使用呈正相关,而年龄较大则是负相关。较长的住院时间、初始出院处方中阿片类药物负荷高以及女性会增加持续使用阿片类药物的风险。相反,手术严重程度较高与持续使用阿片类药物的风险较低相关。
研究结果表明,相当一部分患者在手术后成为持续阿片类药物使用者。确定的风险因素可以指导临床医生以减少阿片类药物相关不良后果的方式进行处方,并有助于指导未来的干预措施。